High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

Jinyang Cai(Virginia Commonwealth University), Anthony C. Faber(Virginia Commonwealth University)
Cell Reports
July 1, 2022
Cited by 18


Related Papers